Clinical Effectiveness and Application Strategies of Bismuth Quadruple Therapy: Analysis of the European Helicobacter Pylori Registry (Hp-EuReg)
(European Registry on Helicobacter pylori Management, Hp-EuReg) 2013 2021 (bismuth quadruple therapies, BQT) , . 1 49690 15582(31%) BQT .BQT 2013 8.6% 2021 39% . BQT (single-capsule BQT, ScBQT) bismuth, metronidazole, tetracycline PPI (protone pump inhibitor) BQT 43% , 90% .
Authors
- Hyun Ho Choi (ORCID: https://orcid.org/0000-0003-0187-3842)
Institutions
- The Catholic University of Korea Uijeongbu St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Published
- 2025-09-02
- DOI
- https://doi.org/10.7704/kjhugr.2025.0040
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00